-
Marina Cavazzana is a
professor of
Paediatric Immunology at the Necker-Enfants
Malades Hospital and the
Imagine Institute, as well as an
academic at Paris...
- 1146/annurev.immunol.22.012703.104614. PMID 15032591.
Fischer A, Hacein-Bey S,
Cavazzana-Calvo M (2002). "Gene
therapy of
severe combined immunodeficiencies"....
-
Human Genome Research Institute. 2009.
Fischer A, Hacein-Bey-Abina S,
Cavazzana-Calvo M (June 2010). "20
years of gene
therapy for SCID".
Nature Immunology...
-
bubble babies) and
curative approaches using gene therapies. With
Marina Cavazzana-Calvo and
Salima Hacein-Bey, he
obtained in 1999, the
first clinical successes...
- (948): 560–70. doi:10.1136/pgmj.2003.017764. PMC 1743106. PMID 15466989.
Cavazzana-Calvo M,
Fischer A (June 2007). "Gene
therapy for
severe combined immunodeficiency:...
-
rhabdomyosarcoma is a
subtype of
embryonal rhabdomyosarcoma first described by
Cavazzana,
Schmidt and
Ninfo in 1992. This
subtype has a more
favorable clinical...
- Philippe; Borwornpinyo, Suparerk; Hongeng, Suradej; Hacein-Bey, Salima;
Cavazzana, Marina; Leboulch, Philippe; Payen,
Emmanuel (February 2016). "Gene Therapy...
- in Paris, France, were
published in the
journal Nature by Drs.
Marina Cavazzana-Calvo and
Philippe Leboulch,
scientific founder of
Genetix Pharmaceuticals...
- News Online.
Retrieved 29
April 2016.
Fischer A, Hacein-Bey-Abina S,
Cavazzana-Calvo M (June 2010). "20
years of gene
therapy for SCID".
Nature Immunology...
-
Leiva L,
Sorensen R,
Wulffraat N,
Blanche S,
Bushman FD,
Fischer A,
Cavazzana-Calvo M (September 2008). "Insertional
oncogenesis in 4
patients after...
